(Enduring Activity) Overcoming Barriers To Hepatitis C Treatment Among Substance Users 10/2/2017

(Enduring Activity) Overcoming Barriers to Hepatitis C Treatment Among Substance Users 10/2/2017

8 Questions

Substance users have the highest prevalence of hepatitis C (HCV) infection but are very rarely treated. Despite recent approval of HCV treatment regimens with almost universal efficacy, complete eradication of HCV will not be possible before all patient populations have access to treatment.

Learning Objectives:
1. Describe HCV transmission routes, prevalence among specific patient populations and new developments in HCV treatment.
2. Define barriers to hepatitis C treatment among people with substance use disorders.
3. Review strategies to overcome barriers to HCV treatment among substance users.

To obtain CME credit, you must complete the evaluation form. This event is approved for 1.5 prescribed credits by AAFP. The credits are also ANCC recognized. Certificates will be generated upon successful completion of the evaluation.

.quizstartForms{ display:none;} #errormsg{ display:block;} #errorInfoDiv{ display:block;}

You don't have javascript enabled. Please enable it to proceed.